Latest filing: Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Allotment
ObservedCompany dossier
Fredun Pharmaceuticals
BSE:FREDUN · ISIN INE194R01017
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Fredun Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 44.57% and public 55.43% as of 16 Jul 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Allotment
BSE · exchange filing
Observed
Source filing Fredun Pharmaceuticals Ltd - 539730 - Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Issue Of Bonus Equity Shares.
BSE · exchange filing
Observed
Source filing Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →16 Jul 2026
- Promoter group
- 44.57%
- Public
- 55.43%
- Employee trust
- N/A
Observed BSE shareholding XBRL